{
    "nct_id": "NCT06500455",
    "official_title": "Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases",
    "brief_title": "Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain",
    "cancer_type_display": "A study comparing fractionated stereotactic radiosurgery (FSRS) to single-fraction stereotactic radiosurgery (SRS) for patients whose cancer has spread to the brain from primary sites such as lung, breast, melanoma, or kidney.",
    "cancer_tags": [
      "Anatomic Stage IV Breast Cancer AJCC v8",
      "Metastatic Breast Carcinoma",
      "Metastatic Digestive System Carcinoma",
      "Metastatic Lung Non-Small Cell Carcinoma",
      "Metastatic Malignant Neoplasm in the Brain",
      "Metastatic Malignant Solid Neoplasm",
      "Metastatic Melanoma",
      "Metastatic Renal Cell Carcinoma",
      "Stage IV Lung Cancer AJCC v8",
      "Stage IV Renal Cell Cancer AJCC v8"
    ],
    "link_to_trial": "https://clinicaltrials.gov/study/NCT06500455",
    "phase": "Phase 3",
    "recruitment_status": "RECRUITING",
    "last_update_date": "2025-09-08",
    "enrollment": 269,
    "min_age": 18,
    "max_age": null,
    "sex": "ALL",
    "is_metastatic_allowed": true,
    "performance_status_scale": "KPS",
    "performance_status_values": null,
    "min_prior_lines": null,
    "max_prior_lines": null,
    "prior_treatments_required": null,
    "prior_treatments_excluded": [
      "Prior radiotherapy to the brain (partial or whole brain irradiation, SRS, FSRS, or prophylactic cranial irradiation [PCI])"
    ],
    "principal_investigator": "Rupesh R Kotecha",
    "site_name": "Banner University Medical Center - Tucson",
    "contact_email": "UACC-IIT@uacc.arizona.edu",
    "contact_phone": null,
    "locations": [
      {
        "facility": "Banner University Medical Center - Tucson",
        "status": "RECRUITING",
        "city": "Tucson",
        "state": "Arizona",
        "zip": "85719",
        "country": "United States",
        "contacts": [
          {
            "name": "Site Public Contact",
            "role": "CONTACT",
            "email": "UACC-IIT@uacc.arizona.edu"
          },
          {
            "name": "Baldassarre Stea",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 32.22174,
          "lon": -110.92648
        }
      },
      {
        "facility": "University of Arizona Cancer Center-North Campus",
        "status": "RECRUITING",
        "city": "Tucson",
        "state": "Arizona",
        "zip": "85719",
        "country": "United States",
        "contacts": [
          {
            "name": "Site Public Contact",
            "role": "CONTACT",
            "email": "UACC-IIT@uacc.arizona.edu"
          },
          {
            "name": "Baldassarre Stea",
            "role": "PRINCIPAL_INVESTIGATOR"
          }
        ],
        "geoPoint": {
          "lat": 32.22174,
          "lon": -110.92648
        }
      }
    ],
    "key_inclusion_summary": [
      "Pathologically proven diagnosis of a solid tumor malignancy (NSCLC, melanoma, breast, renal cell, or GI cancer).",
      "Must have 1 to 8 total intact brain metastases.",
      "At least one lesion must have a maximum diameter of ≥ 1.0 cm and ≤ 3.0 cm.",
      "Karnofsky performance status (KPS) ≥ 60.",
      "Age ≥ 18 years."
    ],
    "key_exclusion_summary": [
      "Prior radiotherapy to the brain.",
      "Known leptomeningeal disease (LMD).",
      "Metastases located in the brainstem or less than 5 mm from the optic nerves or chiasm.",
      "More than 8 total brain metastases.",
      "Karnofsky performance status (KPS) < 60."
    ]
  }